SKB BIO (HKEX: 06990) has disclosed a new financial transaction. On June 3, 2026, the company entered into the China Zheshang Bank Structured Deposit Agreement IV. Under this agreement, SKB BIO has agreed to subscribe for a structured deposit from China Zheshang Bank with a principal amount of RMB 300 million.
As of the date of this announcement, the total outstanding principal amount of the company's wealth management products placed with China Zheshang Bank stands at RMB 590 million. This total comprises three specific structured deposits: (i) a RMB 100 million deposit under Structured Deposit Agreement II, details of which were provided in an April 2026 announcement; (ii) a RMB 190 million deposit under Structured Deposit Agreement III; and (iii) the newly announced RMB 300 million deposit under Structured Deposit Agreement IV.